Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05112757 · ClinicalTrials.gov registry record · NA
Effective Conversion of Individuals at Risk
A NA study, sponsored by Philips Electronics Nederland B.V. acting through Philips CTO organization.
- Terminated
- Registry status
- NA
- Development phase
- 77
- Enrollment target
NCT05112757 is a NA study that was terminated before completion, run by Philips Electronics Nederland B.V. acting through Philips CTO organization. The registered enrollment target is 77 participants.
The verdict
NCT05112757, a NA study, was terminated before completion, sponsored by Philips Electronics Nederland B.V. acting through Philips CTO organization.
- TERMINATED
- Registry status
- NA
- Development phase
- 77 participants
- Enrollment target
Study Summary
This study aims to guide participants in recognizing their OSA (obstructive sleep apnea) and AFib (atrial fibrillation) symptoms, realizing what medical conditions can cause these symptoms (if any) and inform the participants on their possible diagnosis
Interventions
- OTHER Smartphone application use
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 77 participants |
| Start Date | 2022-02-24 |
| Est. Completion | 2022-12-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05112757
The ClinicalTrials.gov registry entry for NCT05112757 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 77 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Philips Electronics Nederland B.V. acting through Philips CTO organization, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Smartphone application use is the first listed.
NCT05112757 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05112757 about?
NCT05112757 is a clinical study titled "Effective Conversion of Individuals at Risk". This study aims to guide participants in recognizing their OSA (obstructive sleep apnea) and AFib (atrial fibrillation) symptoms, realizing what medical conditions can cause these symptoms (if any) and inform the participants on their possible diagnosis
What is the current status of trial NCT05112757?
This trial is currently terminated. It is a NA study. The enrollment target is 77 participants. The study started on 2022-02-24. Estimated completion is 2022-12-08.
What interventions are being tested in trial NCT05112757?
The interventions under investigation include: Smartphone application use (OTHER).
Who is sponsoring clinical trial NCT05112757?
This trial is sponsored by Philips Electronics Nederland B.V. acting through Philips CTO organization, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.